Ascom Wireless Solutions wins two important orders for Ascom Myco in the United States

Jun 8, 2016
Ascom secures two major deals for its purpose-built smartphone Ascom Myco, which will include a deployment of around 1500 Ascom Myco units in the United States.

One of the largest US hospital systems with facilities across 17 states selected Ascom Myco and will install more than 1000 Ascom Myco units. Another large regional healthcare network will roll out about 500 Ascom Myco units.

Ascom Myco is a purpose-built smartphone for healthcare that integrates with specialist healthcare communication systems to optimize clinical workflows and mobilize mission-critical information and communication. Ascom Myco also supports a growing library of healthcare applications. Both projects have promising upsell and growth potential for Ascom to layer in additional solutions.

"We are proud of these two Ascom Myco wins, the largest to date in the American market," says Claes Ödman, General Manager Ascom Wireless Solutions. "Momentum is clearly building for the Ascom Myco, and we will replicate these significant wins by leveraging relationships with the growing network of Ascom Certified Strategic Partners and capitalizing on the huge potential this market represents. We will continue to invest in this market and grow the preference for Ascom solutions at all levels of the healthcare ecosystem."


This document does not constitute an offer or solicitation to subscribe for, purchase or sell any securities. This document is not being issued in the United States of America or the United Kingdom and should not be distributed in any jurisdiction in a manner where such distribution would not comply with regulatory requirements. In particular, this document may not be distributed into the United States, to United States persons or to publications with a general circulation in the United States. In addition, the securities of Ascom have not been and will not be registered in any jurisdiction outside Switzerland. The securities of Ascom may not be offered, sold or delivered and no solicitation to purchase such securities may be made within the United States or to U.S. persons absent an applicable exemption from the registration requirements of the United States securities laws or within any other jurisdiction and in a manner where such offer, sale, delivery or solicitation might not be in compliance with regulatory requirements (including the United Kingdom).